thymine has been researched along with Blood Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Overman, MJ | 1 |
| Kopetz, S | 1 |
| Varadhachary, G | 1 |
| Fukushima, M | 1 |
| Kuwata, K | 1 |
| Mita, A | 1 |
| Wolff, RA | 1 |
| Hoff, P | 1 |
| Xiong, H | 1 |
| Abbruzzese, JL | 1 |
| Waxman, S | 1 |
| Corcino, J | 1 |
| Herbert, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma[NCT04923529] | Phase 2 | 28 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for thymine and Blood Diseases
| Article | Year |
|---|---|
Aggravation or initiation of megaloblastosis by amino acids in the diet.
Topics: Amino Acids; Anemia, Pernicious; Cell Nucleus; Diet; DNA; Erythrocytes; Folic Acid; Folic Acid Defic | 1970 |
1 trial available for thymine and Blood Diseases
| Article | Year |
|---|---|
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neopl | 2008 |